QUOTE AND NEWS
StreetInsider.com  May 9  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Net+1+UEPS+Technologies%2C+Inc.+%28UEPS%29+Tops+Q3+EPS+by+3c/8324283.html for the full story.
StreetInsider.com  Feb 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Net+1+UEPS+Technologies%2C+Inc.+%28UEPS%29+Misses+Q2+EPS+by+4c/8071548.html for the full story.
Benzinga  Dec 6  Comment 
Below are highlights from Benzinga's daily coverage of small cap securities making big moves: Net 1 UEPS Technologies Shares of Net 1 UEPS Technologies (NASDAQ: UEPS), the Johannesburg, South Africa provider of payment solutions and...
StreetInsider.com  Dec 5  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/UEPS+Technologies+%28UEPS%29+Ties+SEC+DOJ+Investigation+to+Competitor+AllPay/7925752.html for the full story.
StreetInsider.com  Dec 4  Comment 
Net 1 Ueps Technologies Inc. (Nasdaq: UEPS) 56.8% LOWER; under a probe by the FBI and U.S.DOJ over dealings in South Africa. Geron Corp (Nasdaq: GERN) 25.0% LOWER; announced that the company has discontinued development of GRN1005, its...
Benzinga  Dec 4  Comment 
Net 1 Ueps Technologies (NASDAQ: UEPS) shares lost 50.64% to create a new 52-week low of $3.87. Net 1 Ueps Technologies' trailing-twelve-month ROA is 4.07%. Cereplast (NASDAQ: CERP) shares fell 6.55% to touch a new 52-week low of $0.0785....
Benzinga  Dec 4  Comment 
Net 1 Ueps Technologies (NASDAQ: UEPS) shares dipped 46.17% to $4.22 at 9:52 am. Net 1 Ueps Technologies' trailing-twelve-month ROA is 4.07%. Geron (NASDAQ: GERN) shares lost 31.08% to $1.02. Geron announced its plans to end development of...
StreetInsider.com  Nov 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Net+1+UEPS+Technologies%2C+Inc.+%28UEPS%29+Misses+Q1+EPS+by+1c/7859533.html for the full story.
StreetInsider.com  Aug 24  Comment 
Aruba Networks, Inc. (NASDAQ: ARUN) 18.0% HIGHER; reported Q4 EPS of $0.18, $0.01 better than the analyst estimate of $0.17. Revenue for the quarter came in at $139.2 million versus the consensus estimate of $136.84 million. Hemispherx Biopharma,...
StreetInsider.com  Aug 23  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Net+1+UEPS+Technologies%2C+Inc.+%28UEPS%29+Reports+Q4+Non-GAAP+EPS+of+%240.27%2C+Beats+Views/7683306.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki